Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources
News and Community
About us

Apotex Pty Ltd

Regulatory activities for this sponsor.

Loading...

Cancellation by sponsor (1354) Cancellation by sponsor (1354)
Cancellation or suspension (47) Cancellation or suspension (47)
Prescription medicine registration (18)
ARTG (3) ARTG (3)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1) Section 14, TGO91 consent (1)

2024 (4) 2024 (4)
2023 (16) 2023 (16)
2022 (159) 2022 (159)
2021 (104) 2021 (104)
2020 (216) 2020 (216)
2019 (124) 2019 (124)
2018 (380) 2018 (380)
2017 (302) 2017 (302)
2016 (37) 2016 (37)
2015 (52) 2015 (52)
2014 (32) 2014 (32)

Search

Sponsor content

1426 result(s) found, displaying 1381 to 1390

CHEMMART ENALAPRIL enalapril maleate 10mg tablet blister pack Cancelled under s30(1)(c) of the Act

2 June 2015

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART ENALAPRIL enalapril maleate 20mg tablet blister pack Cancelled under s30(1)(c) of the Act

2 June 2015

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS ENALAPRIL enalapril maleate 5mg tablet blister pack Cancelled under s30(1)(c) of the Act

2 June 2015

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS ENALAPRIL enalapril maleate 10mg tablet blister pack Cancelled under s30(1)(c) of the Act

2 June 2015

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS ENALAPRIL enalapril maleate 20mg tablet blister pack Cancelled under s30(1)(c) of the Act

2 June 2015

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Temozolomide temozolomide 140 mg capsule bottle Cancelled under s30(1)(c )

16 March 2015

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Temozolomide temozolomide 180 mg capsule bottle Cancelled under s30(1)(c )

16 March 2015

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Temozolomide temozolomide 20 mg capsule bottle Cancelled under s30(1)(c )

16 March 2015

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Temozolomide temozolomide 250 mg capsule bottle Cancelled under s30(1)(c )

16 March 2015

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Temozolomide temozolomide 5 mg capsule bottle Cancelled under s30(1)(c )

16 March 2015

Cancellation by sponsor

Requested by Apotex Pty Ltd

Pages

First page
Previous page
…
Page 135
Page 136
Page 137
Page 138
Current page 139
Page 140
Page 141
Page 142
Page 143
Next page
Last page

Is there anything wrong with this page?

Help us improve this page

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control - external site
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook - external site
(formerly Twitter) - external site
Youtube - external site
Instagram - external site
LinkedIn - external site

Help us improve

We are always looking for ways to improve our website.

Provide feedback - external site

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

Apotex Pty Ltd

Type

Date

Help us improve this page